Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis

Previous work has reported the important links between cellular bioenergetics and the development of chronic kidney disease, highlighting the potential for targeting metabolic functions to regulate disease progression. More recently, it has been shown that alterations in fatty acid oxidation (FAO) c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Price, Nathan L., Miguel, Verónica, Ding, Wen, Singh, Abhishek K., Malik, Shipra, Rotllan, Noemi, Moshnikova, Anna, Toczek, Jakub, Zeiss, Caroline, Sadeghi, Mehran M., Arias, Noemi, Baldán, Ángel, Andreev, Oleg A., Rodríguez-Puyol, Diego, Bahal, Raman, Reshetnyak, Yana K., Suárez, Yajaira, Fernández-Hernando, Carlos, Lamas, Santiago
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6948871/
https://ncbi.nlm.nih.gov/pubmed/31613798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.131102
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados